Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Marijuana Use in Adolescents with IBD

J Pediatr; ePub 2018 Apr 16; Hoffenberg, et al

Marijuana use by adolescents and young adults with inflammatory bowel disease (IBD) is common and beneficial, a recent study found. The cross-sectional study included patients aged 13 to 23 years from the Children’s Hospital Colorado for IBD enrolled between December 2015 through June 2017. Researchers found:

  • Among 99 participants, marijuana ever-use was endorsed by 32% and daily or almost daily use by 9%.
  • Older age was the only characteristic associated with endorsing marijuana use.
  • Users were 10.7 times more likely to perceive low risk of harm with regular use.
  • At least 1 medical reason for use was endorsed by 57% of participants, most commonly for relief of physical pain.
  • The most common route of use was smoking, followed by edibles, dabbing, and vaping.

Citation:

Hoffenberg EJ, McWilliams SK, Mikulich-Gilbertson SK, et al. Marijuana use by adolescents and young adults with inflammatory bowel disease. [Published online ahead of print April 16, 2018]. J Pediatr. doi:10.1016/j.jpeds.2018.03.041.

This Week's Must Reads

Acute Illness and Cannabis Use in Adults, Ann Intern Med; ePub 2019 Mar 26; Monte, et al

Pregnancy History and Risk of Miscarriage, BMJ; ePub 2019 Mar 20; Magnus, et al

Firearms Mortality Among US Schoolchildren, Am J Med; ePub 2019 Mar 25; Rubenstein, et al

Rapid Point of Care Test for Influenza, J Am Board Fam Med; 2019 Mar; Dale, et al

Sleep Disturbance and Chronic Pain Intensity, Clin J Pain; ePub 2019 Mar 25; Burgess, et al

Must Reads in Gastroenterology

Psychological Screening for Youth with Abdominal Pain, Pediatrics; ePub 2018 Jul 25; Cunningham, et al

Mortality Due to Cirrhosis & Liver Cancer in the US, BMJ; ePub 2018 Jul 18; Tapper, Parikh

Marijuana Use in Adolescents with IBD, J Pediatr; ePub 2018 Apr 16; Hoffenberg, et al

Oral Capsule vs Colonoscopy FMT for CDI, JAMA; 2017 Nov 28; Kao, Roach, et al

Tofacitinib as Induction & Maintenance Therapy, N Engl J Med; 2017 May 4; Sandborn, et al